Pentosan polysulfate ameliorates fibrosis and inflammation markers in SV40 MES13 cells by suppressing activation of PI3K/AKT pathway via miR-446a-3p

BACKGROUND: Renal fibrosis is a common outcome of various renal damage, including diabetic nephropathy (DN), the leading cause of end-stage renal disease. Currently, there are no effective therapies for renal fibrosis. The present study aimed to determine whether pentosan polysulphate sodium (PPS),...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Liangxiang, Chen, Anqun, Gao, Qing, Xu, Bo, Guo, Xiaodan, Guan, Tianjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925175/
https://www.ncbi.nlm.nih.gov/pubmed/35291969
http://dx.doi.org/10.1186/s12882-022-02732-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925175/
https://www.ncbi.nlm.nih.gov/pubmed/35291969
http://dx.doi.org/10.1186/s12882-022-02732-8

Ejemplares similares